Evidence map›Paper›PMID 25889056›Full record

ArticleRetrovirology2015

Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication.

Steffen Erkelenz, Frank Hillebrand, Marek Widera, Stephan Theiss, Anaam Fayyaz, Daniel Degrandi, Klaus Pfeffer, Heiner Schaal

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Transcriptomic Analysis Reveals Key Pathways Influenced by HIV-2 Vpx.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.Frontiers in cellular and infection microbiology · 2022
    Review
  13. Article
  14. Article
  15. Splicing factor SRSF2-centric gene regulation.International journal of biological sciences · 2021
    Review
  16. Targeting Splicing Factor SRSF6 for Cancer Therapy.Frontiers in cell and developmental biology · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Steffen ErkelenzInstitute of Virology, Heinrich-Heine-University Düsseldorf, D-40225, Düsseldorf, Germany. Steffen.Erkelenz@med.uni-duesseldorf.de.
Frank HillebrandInstitute of Virology, Heinrich-Heine-University Düsseldorf, D-40225, Düsseldorf, Germany. Frank.Hillebrand@med.uni-duesseldorf.de.
Marek WideraInstitute of Virology, Heinrich-Heine-University Düsseldorf, D-40225, Düsseldorf, Germany. Marek.Widera@uk-essen.de.
Stephan TheissInstitute of Clinical Neuroscience and Medical Psychology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. theiss@uni-duesseldorf.de.
Anaam FayyazPlant Biology Laboratories, Michigan State University, Michigan, USA. fayyazan@msu.edu.
Daniel DegrandiInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, D-40225, Düsseldorf, Germany. Daniel.Degrandi@uni-duesseldorf.de.
Klaus PfefferInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University Düsseldorf, D-40225, Düsseldorf, Germany. klaus.pfeffer@uni-duesseldorf.de.
Heiner SchaalInstitute of Virology, Heinrich-Heine-University Düsseldorf, D-40225, Düsseldorf, Germany. schaal@uni-duesseldorf.de.
Heinrich Heine University Düsseldorf · DEEssen University Hospital · DEMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe viral regulatory protein Tat is essential for establishing a productive transcription from the 5'-LTR promoter during the early phase of viral gene expression. Formation of the Tat-encoding mRNAs requires splicing at the viral 3'ss A3, which has previously been shown to be both negatively and positively regulated by the downstream splicing regulatory elements (SREs) ESS2p and ESE2/ESS2. However, using the novel RESCUE-type computational HEXplorer algorithm, we were recently able to identify another splicing enhancer (ESE(5807-5838), henceforth referred to as ESE tat ) located between ESS2p and ESE2/ESS2. Here we show that ESE tat has a great impact on viral tat-mRNA splicing and that it is fundamental for regulated 3'ss A3 usage.

resultsMutational inactivation or locked nucleic acid (LNA)-directed masking of the ESE tat sequence in the context of a replication-competent virus was associated with a failure (i) to activate viral 3'ss A3 and (ii) to accumulate Tat-encoding mRNA species. Consequently, due to insufficient amounts of Tat protein efficient viral replication was drastically impaired. RNA in vitro binding assays revealed SRSF2 and SRSF6 as candidate splicing factors acting through ESE tat and ESE2 for 3'ss A3 activation. This notion was supported by coexpression experiments, in which wild-type, but not ESE tat -negative provirus responded to higher levels of SRSF2 and SRSF6 proteins with higher levels of tat-mRNA splicing. Remarkably, we could also find that SRSF6 overexpression established an antiviral state within provirus-transfected cells, efficiently blocking virus particle production. For the anti-HIV-1 activity the arginine-serine (RS)-rich domain of the splicing factor was dispensable.

conclusionsBased on our results, we propose that splicing at 3'ss A3 is dependent on binding of the enhancing SR proteins SRSF2 and SRSF6 to the ESE tat and ESE2 sequence. Mutational inactivation or interference specifically with ESE tat activity by LNA-directed masking seem to account for an early stage defect in viral gene expression, probably by cutting off the supply line of Tat that HIV needs to efficiently transcribe its genome.

Indexed as

Regulatory Sequences, Ribonucleic AcidRNA SplicingVirus ReplicationCell LineDNA Mutational AnalysisGene ExpressionHIV-1HumansNuclear ProteinsPhosphoproteinsProtein BindingRibonucleoproteinsRNA-Binding ProteinsSerine-Arginine Splicing Factorstat Gene Products, Human Immunodeficiency VirusNuclear ProteinsPhosphoproteinsRegulatory Sequences, Ribonucleic AcidRibonucleoproteinsRNA-Binding ProteinsSerine-Arginine Splicing FactorsSRSF2 protein, humanSRSF6 protein, humantat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID25889056
PMCPMC4422144
OpenAlexW2025001392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.